Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 5/20/10 → 5/20/13 |
Funding
- Boehringer Ingelheim Pharmaceuticals, Inc. (511.156)
Prot# 511.156: A Twenty-Four Week, Randomized, Double-Blind, Placebo-Controlled, Safety And Efficacy Trial of Flibanserin, With Up-Titration, 100 Milligrams Administered Orally Once Daily in Naturally Postmenopausal Women With Hypoactive Sexual Desire Dis
- Stika, Catherine Susan (PD/PI)
- Dungan, Jeffrey S (Co-PD/PI)
- Luthringshausen, Michelle M (Co-PD/PI)
- Shulman, Lee P (Co-PD/PI)
Project: Research project